Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | M-76-004 |
Topic: | High Resolution Anoscopy (HRA) |
Section: | Diagnostic Medical |
Effective Date: | January 1, 2016 |
Issue Date: | July 9, 2018 |
Last Reviewed: | June 2018 |
High Resolution Anoscopy (HRA) also known as colposcopy of the anal canal is a procedure used in the treatment and surveillance of anal dysplasia and the prevention of anal cancer. It is performed on patients with an abnormal anal cytology or anal Pap test. Anal Pap tests are obtained on individuals who are at risk for genital or anal human papillomavirus (HPV) infections, even in the absence of signs or symptoms of infection. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
HRA may be considered medically necessary for ANY ONE of the following conditions:
HRA for all other indications is considered experimental/investigational and therefore, non-covered due to lack of scientific evidence in the published peer reviewed literature.
Place of Service: Inpatient/Outpatient |
Experimental/Investigational (E/I) services are not covered regardless of place of service.
HRA is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.
The policy position applies to all commercial lines of business |
Denial Statements |
Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Links |
03/2015, Coverage Established for High Resolution Anoscopy (HRA)